• Aucun résultat trouvé

lupus erythematosus

Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.

Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.

... (3) have SARS- CoV-2 carriage in their nasopharyngeal swab, as confirmed by real- time reverse transcription PCR analysis. Data were collected from 17 patients with SLE between 29 March and 6 April ( tables 1 and 2 ). ...

4

Neuro-psychiatric manifestations in systemic lupus erythematosus: new concepts from a mono-center retrospective study

Neuro-psychiatric manifestations in systemic lupus erythematosus: new concepts from a mono-center retrospective study

... Systemic Lupus Erythematosus: The Evidence and the ...Systemic Lupus Erythematosus with Neuropsychiatric Manifestations: Report of a Task Force of the EULAR Standing Committee for Clinical ...

40

The Current Concept of T[subscript H]17 Cells and Their Expanding Role in  Systemic Lupus Erythematosus

The Current Concept of T[subscript H]17 Cells and Their Expanding Role in Systemic Lupus Erythematosus

... Copyright © 2011 Daniel Perry et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...

11

PReS-FINAL-2353: Are rasopathies new monogenic predisposing conditions to the development of systemic lupus erythematosus?

PReS-FINAL-2353: Are rasopathies new monogenic predisposing conditions to the development of systemic lupus erythematosus?

... RASopathies (Noonan syndrome (NS) and Noonan-related syndromes) are neurodevelopmental syndromes resulting from germline mutations in genes that participate in the rat sarcoma/mitogen-activated protein kinases (RAS/ ...

2

SPRi-Based Strategy to Identify Specific Biomarkers in Systemic Lupus Erythematosus, Rheumatoid Arthritis and Autoimmune Hepatitis

SPRi-Based Strategy to Identify Specific Biomarkers in Systemic Lupus Erythematosus, Rheumatoid Arthritis and Autoimmune Hepatitis

... Materials and Methods Sera studied Sera from patients and blood donors were collected (Laboratoire d’Immunologie, Hôpital Saint-Antoine, Paris, France), with approval of the Committee of the Biobanque du Centre ...

11

Safety and efficacy of low-dose intravenous arsenic trioxide in systemic lupus erythematosus: an open-label phase IIa trial (Lupsenic)

Safety and efficacy of low-dose intravenous arsenic trioxide in systemic lupus erythematosus: an open-label phase IIa trial (Lupsenic)

... Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease characterised by overproduction of type I interferons, hyperactivity of B cells with production of antibodies, presence of ...

12

Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation.

Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation.

... in Lupus Erythematosus National Assessment-Systemic Lupus Erythematosus Disease Activity Index; SLE: systemic lupus erythematosus; Th17: T helper lymphocytes producing IL-17; ...

11

Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity.

Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity.

... (a) Total microparticles (MPs); (b) platelet-derived MPs; (c) leukocyte-derived MPs in patients with primary Sjögren's syndrome (pSS), systemic lupus erythematosus (SLE), rheumatoid art[r] ...

12

Identification and characterization of novel molecular causes of primary immunodeficiency : RELA mutations are associated to common variable immunodeficiency and systemic lupus erythematosus

Identification and characterization of novel molecular causes of primary immunodeficiency : RELA mutations are associated to common variable immunodeficiency and systemic lupus erythematosus

... Systemic Lupus Erythematosus associated to PID Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease with potential lethal ...

132

The role of DcR3 in systemic lupus erythematosus and islet β-Cell viability and function

The role of DcR3 in systemic lupus erythematosus and islet β-Cell viability and function

... RESULTS DcR3 Tg islets secrete DcR3 To continuously supply biologically active DcR3 to islets, DcR3 Tg mice were generated in both the C3H x C57BL/6 and C57BL/6 backgrounds, using the human β-actin promoter, as ...

225

Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments.

Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments.

... characteristics, hydroxychloroquine use and immunosuppressive treatments We read with interest the article of Bozzalla Cassione et al about COVID-19 incidence in their systemic lupus erythematosus (SLE) ...

2

Association between the Presence of Autoantibodies Targeting Ficolin-3 and Active Nephritis in Patients with Systemic Lupus Erythematosus

Association between the Presence of Autoantibodies Targeting Ficolin-3 and Active Nephritis in Patients with Systemic Lupus Erythematosus

... Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) [ 26 ] at the time of sampling were ...active lupus nephritis (LN) documented by kidney biopsy (classes I, II, III, IV or V of the ISN/RPS ...

16

Evaluation of Hydroxychloroquine Blood Concentrations and Effects in Childhood-Onset Systemic Lupus Erythematosus

Evaluation of Hydroxychloroquine Blood Concentrations and Effects in Childhood-Onset Systemic Lupus Erythematosus

... 9. Groot, N.; de Graeff, N.; Avcin, T.; Bader-Meunier, B.; Brogan, P.; Dolezalova, P.; Feldman, B.; Kone-Paut, I.; Lahdenne, P.; Marks, S.D.; et al. European evidence-based recommendations for diagnosis and treatment of ...

12

Autoantibodies targeting ficolin-2 in systemic lupus erythematosus patients with active nephritis

Autoantibodies targeting ficolin-2 in systemic lupus erythematosus patients with active nephritis

... Accepted Article l’Informatique et des Libertés”, CNIL N°2030950vO). The study has also been registered to clinicaltrial.gov (N° NCT03063281). The study was done in accordance with the Declaration of Helsinki and Good ...

14

Basophils and Autoreactive IgE in the Pathogenesis of Systemic Lupus Erythematosus.: Basophils in Lupus

Basophils and Autoreactive IgE in the Pathogenesis of Systemic Lupus Erythematosus.: Basophils in Lupus

... human lupus including the development of lupus nephritis. As early as 20 weeks of age, Lyn deficient mice show glomerular deposits of anti-dsDNA IgG antibodies and circulating immune complexes. They ...

23

4SC-101, A Novel Small Molecule Dihydroorotate Dehydrogenase Inhibitor, Suppresses Systemic Lupus Erythematosus in MRL-(Fas)lpr Mice

4SC-101, A Novel Small Molecule Dihydroorotate Dehydrogenase Inhibitor, Suppresses Systemic Lupus Erythematosus in MRL-(Fas)lpr Mice

... (Figure 4A) as evidenced by semiquantitative morpho- metrical evaluation, eg, by assessing the activity and chronicity scores of lupus nephritis (Figure 4B). The activity score, a composite score of mostly ...

8

MicroRNA Profiling of B Cell Subsets from Systemic Lupus Erythematosus Patients Reveals Promising Novel Biomarkers

MicroRNA Profiling of B Cell Subsets from Systemic Lupus Erythematosus Patients Reveals Promising Novel Biomarkers

... populations. In addition, while miRNA-mediated deregulation in SLE has been studied mostly in whole blood or isolated T cells, there are fewer studies that systematically report miRNA changes in lupus B cells. ...

14

Expression of CXCL12 receptors in B cells from Mexican Mestizos patients with systemic lupus erythematosus.

Expression of CXCL12 receptors in B cells from Mexican Mestizos patients with systemic lupus erythematosus.

... Chemokines are small cytokine-like secreted proteins that govern migration of leukocytes to specific niches in lymphoid organs and inflammatory sites. They mediate their functions by binding and activating chemokine ...

17

Heart Involvement in a Woman Treated with Hydroxychloroquine for Systemic Lupus Erythematosus Revealing Fabry Disease

Heart Involvement in a Woman Treated with Hydroxychloroquine for Systemic Lupus Erythematosus Revealing Fabry Disease

... L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignemen[r] ...

4

Lupus et grossesse ( A propos de 02 cas et revue de la littérature )

Lupus et grossesse ( A propos de 02 cas et revue de la littérature )

... in Lupus Erythematosus National Assessment) [in100] ; a porté sur un collectif de 183 femmes lupiques dont avaient été exclues les patientes avec un syndrome d'anticorps antiphospholipides ou porteuses ...

112

Show all 75 documents...

Sujets connexes